Abstract
BackgroundNeuroendocrine tumors (NET), including small cell lung cancer (SCLC), have poor prognosis and limited therapeutic options. AMG 757 is an HLE BiTE® immune therapy designed to redirect T cell cytotoxicity...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have